Bye-law 2, National Medical Commission (Licensing of The import of drugs) Bye-laws, 2022 [SD6-ZNN]

As at 7 September 2026. In force from 15 October 2022.

In National Medical Commission (Licensing of The import of drugs) Bye-laws, 2022 [R1M-SGR]. This text from 15 October 2022. No other text held.

Synthetic. This instrument, its title, its number and the words of this section are generated by the register.

Cite: Bye-law 2, National Medical Commission (Licensing of The import of drugs) Bye-laws, 2022 [SD6-ZNN]. Machine: SD6-ZNN.

Definitions.—In these bye-laws, unless the context otherwise requires,— (a) "Act" means the National Medical Commission Act, 2019 (30 of 2019); (b) "importer of drugs" means a person carrying on the import of drugs; (c) "stock register" means a stock register received, held or disposed of by a importer of drugs in the course of the import of drugs; (d) "Form 21" means the form so numbered in the Schedule; (e) words and expressions used herein and not defined but defined in the Act shall have the meanings respectively assigned to them in the Act.

Defined terms in this text (0)

none

Made under this bye-law, or naming it (0)

none

Cited by (0)

none

Not held (0)

none

Duties published under this bye-law (0)

none